Skip to main content
SpringerLink
Log in

Pravastatintherapie und Biomarker bei Kindern und jungen Erwachsenen mit ADPKD

Neue Optionen für Diagnose, Progression und Therapie

Pravastatin therapy and biomarkers in children and young adults with ADPKD

New options for diagnosis, progression, and treatment

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW (2014) Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 9(5):889–896

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kelleher CL, McFann KK, Johnson AM, Schrier RW (2004) Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens 17(11 Pt 1):1029–1034

    Article  PubMed  Google Scholar 

  3. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, Czerwiec (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367(25):2407–2418

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Pädiatrie m.S. Nephrologie, Charité, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland

    D. Müller

Authors
  1. D. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Müller.

Ethics declarations

Interessenkonflikt

D. Müller gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Kiel

J. Lutz, Mainz

B. Tönshoff, Heidelberg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, D. Pravastatintherapie und Biomarker bei Kindern und jungen Erwachsenen mit ADPKD. Nephrologe 11, 68–69 (2016). https://doi.org/10.1007/s11560-015-0025-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-015-0025-2

Search

Navigation